Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines

Cytokine

Volumn 75, Issue 1, 2015, Pages 197-206

  Bassagañas, Sònia ^a   Allende, Helena ^b   Cobler, Lara ^c   Ortiz, M Rosa ^d   Llop, Esther ^a   de Bolós, Carme ^b   Peracaula, Rosa ^a  

^a UNIVERSITY OF GIRONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Cytokines; Fucosyltransferases; Lewis antigens; Pancreatic adenocarcinoma; Sialyltransferases

Indexed keywords

GLYCOSYLTRANSFERASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; SIALYL LEWIS X ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; 5-ACETYLNEURAMINYL-(2-3)-GALACTOSYL-(1-4)-(FUCOPYRANOSYL-(1-3))-N-ACETYLGLUCOSAMINE; CD15 ANTIGEN; CYTOKINE; EPITOPE; OLIGOSACCHARIDE; POLYSACCHARIDE; SIALIC ACID DERIVATIVE;

ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FLOW CYTOMETRY; FUT1 GENE; FUT2 GENE; FUT5 GENE; FUT6 GENE; FUT7 GENE; GENE; GENE EXPRESSION REGULATION; GLYCOSYLATION; GLYCOSYLTRANSFERASE GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; PANCREAS ADENOCARCINOMA; PANCREATIC CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; ST3GAL3 GENE; ST3GAL4 GENE; ST6GAL1 GENE; TUMOR MICROENVIRONMENT; CHEMISTRY; DISEASE COURSE; INFLAMMATION; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; TUMOR CELL LINE;

ANTIGENS, CD15; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CYTOKINES; DISEASE PROGRESSION; EPITOPES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; OLIGOSACCHARIDES; PANCREATIC NEOPLASMS; POLYSACCHARIDES; SIALIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84938740862     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.04.006     Document Type: Article

References (70)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
2. Duffy J.P., Eibl G., Reber H.A., Hines O.J. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer 2003, 2:12.
3. Hernandez-Munoz I., Skoudy A., Real F.X., Navarro P. Pancreatic ductal adenocarcinoma: cellular origin, signaling pathways and stroma contribution. Pancreatology 2008, 8:462-469.
4. Inman K.S., Francis A.A., Murray N.R. Complex role for the immune system in initiation and progression of pancreatic cancer. World J Gastroenterol 2014, 20:11160-11181.
5. Esposito I., Menicagli M., Funel N., Bergmann F., Boggi U., Mosca F., et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004, 57:630-636.
6. Mahadevan D., Von Hoff D.D. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther 2007, 6:1186-1197.
7. Weber A., Wasiliew P., Kracht M. Interleukin-1 (IL-1) pathway. Sci Signal 2010, 3. cm1.
8. Karin M., Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005, 5:749-759.
9. Norman J.G., Fink G.W., Denham W., Yang J., Carter G., Sexton C., et al. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci 1997, 42:1783-1788.
10. Viedma J.A., Perez-Mateo M., Dominguez J.E., Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992, 33:1264-1267.
11. Matull W.R., Pereira S.P., O'Donohue J.W. Biochemical markers of acute pancreatitis. J Clin Pathol 2006, 59:340-344.
12. Motoo Y., Xie M.J., Mouri H., Sawabu N. Expression of interleukin-8 in human obstructive pancreatitis. JOP 2004, 5:138-144.
13. Satomura Y., Sawabu N., Takemori Y., Ohta H., Watanabe H., Okai T., et al. Expression of various sialylated carbohydrate antigens in malignant and nonmalignant pancreatic tissues. Pancreas 1991, 6:448-458.
14. Peracaula R., Tabares G., Lopez-Ferrer A., Brossmer R., de Bolos C., de Llorens R. Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells. Glycoconjugate J 2005, 22:135-144.
15. Nakamori S., Nishihara S., Ikehara Y., Nagano H., Dono K., Sakon M., et al. Molecular mechanism involved in increased expression of sialyl Lewis antigens in ductal carcinoma of the pancreas. J Exp Clin Cancer Res 1999, 18:425-432.
16. Rambaruth N.D., Dwek M.V. Cell surface glycan-lectin interactions in tumor metastasis. Acta Histochem 2011, 113:591-600.
17. Harduin-Lepers A., Krzewinski-Recchi M.A., Colomb F., Foulquier F., Groux-Degroote S., Delannoy P. Sialyltransferases functions in cancers. Front Biosci (Elite Ed) 2012, 4:499-515.
18. Dall'Olio F., Malagolini N., Trinchera M., Chiricolo M. Mechanisms of cancer-associated glycosylation changes. Front Biosci (Landmark Ed) 2012, 17:670-699.
19. Higai K., Miyazaki N., Azuma Y., Matsumoto K. Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene. FEBS Lett 2006, 580:6069-6075.
20. Radhakrishnan P., Chachadi V., Lin M.F., Singh R., Kannagi R., Cheng P.W. TNFalpha enhances the motility and invasiveness of prostatic cancer cells by stimulating the expression of selective glycosyl- and sulfotransferase genes involved in the synthesis of selectin ligands. Biochem Biophys Res Commun 2011, 409:436-441.
21. Colomb F., Vidal O., Bobowski M., Krzewinski-Recchi M.A., Harduin-Lepers A., Mensier E., et al. TNF induces the expression of the sialyltransferase ST3Gal IV in human bronchial mucosa via MSK1/2 protein kinases and increases FliD/sialyl-Lewisx mediated adhesion of Pseudomonas aeruginosa. Biochem J 2013.
22. Groux-Degroote S., Krzewinski-Recchi M.A., Cazet A., Vincent A., Lehoux S., Lafitte J.J., et al. IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa. Biochem J 2008, 410:213-223.
23. Frazier M.L., Pathak S., Wang Z.W., Cleary K., Singletary S.E., Olive M., et al. Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3. Pancreas 1990, 5:8-16.
24. Frazier M.L., Fernandez E., de Llorens R., Brown N.M., Pathak S., Cleary K.R., et al. Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells. Int J Pancreatol 1996, 19:31-38.
25. Padro M., Mejias-Luque R., Cobler L., Garrido M., Perez-Garay M., Puig S., et al. Regulation of glycosyltransferases and Lewis antigens expression by IL-1beta and IL-6 in human gastric cancer cells. Glycoconjugate J 2011, 28:99-110.
26. Petretti T., Kemmner W., Schulze B., Schlag P.M. Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 2000, 46:359-366.
27. Julien S., Krzewinski-Recchi M.A., Harduin-Lepers A., Gouyer V., Huet G., Le Bourhis X., et al. Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA. Glycoconjugate J 2001, 18:883-893.
28. Schneider F., Kemmner W., Haensch W., Franke G., Gretschel S., Karsten U., et al. Overexpression of sialyltransferase CMP-sialic acid: Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. Cancer Res 2001, 61:4605-4611.
29. Mas E., Pasqualini E., Caillol N., El Battari A., Crotte C., Lombardo D., et al. Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines. Glycobiology 1998, 8:605-613.
30. Pérez-Garay M., Arteta B., Pages L., de Llorens R., de Bolos C., Vidal-Vanaclocha F., et al. alpha23-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo. PLoS One 2010, 5.
31. Higai K., Ishihara S., Matsumoto K. NFkappaB-p65 dependent transcriptional regulation of glycosyltransferases in human colon adenocarcinoma HT-29 by stimulation with tumor necrosis factor alpha. Biol Pharm Bull 2006, 29:2372-2377.
32. De Bolos C., Garrido M., Real F.X. MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 1995, 109:723-734.
33. Lopez-Ferrer A., de Bolos C., Barranco C., Garrido M., Isern J., Carlstedt I., et al. Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium. Gut 2000, 47:349-356.
34. Weiman S., Dahesh S., Carlin A.F., Varki A., Nizet V., Lewis A.L. Genetic and biochemical modulation of sialic acid O-acetylation on group B Streptococcus: phenotypic and functional impact. Glycobiology 2009, 19:1204-1213.
35. Harduin-Lepers A., Mollicone R., Delannoy P., Oriol R. The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach. Glycobiology 2005, 15:805-817.
36. Ma B., Simala-Grant J.L., Taylor D.E. Fucosylation in prokaryotes and eukaryotes. Glycobiology 2006, 16. 158R-84R.
37. Takashima S., Tsuji S., Tsujimoto M. Comparison of the enzymatic properties of mouse beta-galactoside alpha2,6-sialyltransferases, ST6Gal I and II. J Biochem 2003, 134:287-296.
38. Varki A., Schauer R. Sialic acids. Essentials of glycobiology 2009, 199-217. Cold Spring Harbor Laboratory Press, New York. 2nd ed. A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi (Eds.).
39. Pérez-Garay M., Arteta B., Llop E., Cobler L., Pages L., Ortiz R., et al. Alpha2,3-sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues. Int J Biochem Cell Biol 2013, 45:1748-1757.
40. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
41. Bracci P.M., Wang F., Hassan M.M., Gupta S., Li D., Holly E.A. Pancreatitis and pancreatic cancer in two large pooled case-control studies. Cancer Causes Control 2009, 20:1723-1731.
42. Farrow B., Evers B.M. Inflammation and the development of pancreatic cancer. Surg Oncol 2002, 10:153-169.
43. Azuma Y., Murata M., Matsumoto K. Alteration of sugar chains on alpha(1)-acid glycoprotein secreted following cytokine stimulation of HuH-7 cells in vitro. Clin Chim Acta 2000, 294:93-103.
44. Kuninaka S., Yano T., Yokoyama H., Fukuyama Y., Terazaki Y., Uehara T., et al. Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells. Cytokine 2000, 12:8-11.
45. Ishibashi Y., Inouye Y., Okano T., Taniguchi A. Regulation of sialyl-Lewis x epitope expression by TNF-alpha and EGF in an airway carcinoma cell line. Glycoconjugate J 2005, 22:53-62.
46. Delmotte P., Degroote S., Merten M.D., Van Seuningen I., Bernigaud A., Figarella C., et al. Influence of TNFalpha on the sialylation of mucins produced by a transformed cell line MM-39 derived from human tracheal gland cells. Glycoconjugate J 2001, 18:487-497.
47. Colomb F., Krzewinski-Recchi M.A., El Machhour F., Mensier E., Jaillard S., Steenackers A., et al. TNF regulates sialyl-Lewisx and 6-sulfo-sialyl-Lewisx expression in human lung through up-regulation of ST3GAL4 transcript isoform BX. Biochimie 2012, 94:2045-2053.
48. Taniguchi A., Saito K., Kubota T., Matsumoto K. Characterization of the promoter region of the human Galbeta1,3(4)GlcNAc alpha2,3-sialyltransferase III (hST3Gal III) gene. Biochim Biophys Acta 2003, 1626:92-96.
49. Higai K., Miyazaki N., Azuma Y., Matsumoto K. Transcriptional regulation of the fucosyltransferase VI gene in hepatocellular carcinoma cells. Glycoconjugate J 2008, 25:225-235.
50. Neesse A., Gress T.M., Michl P. Therapeutic targeting of apoptotic pathways: novel aspects in pancreatic cancer. Curr Pharm Biotechnol 2012, 13:2273-2282.
51. Fujioka S., Son K., Onda S., Schmidt C., Scrabas G.M., Okamoto T., et al. Desensitization of NFkappaB for overcoming chemoresistance of pancreatic cancer cells to TNF-alpha or paclitaxel. Anticancer Res 2012, 32:4813-4821.
52. Holcomb B., Yip-Schneider M., Schmidt C.M. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy. Pancreas 2008, 36:225-235.
53. Scheller J., Ohnesorge N., Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 2006, 63:321-329.
54. Huang C., Yang G., Jiang T., Huang K., Cao J., Qiu Z. Effects of IL-6 and AG490 on regulation of Stat3 signaling pathway and invasion of human pancreatic cancer cells in vitro. J Exp Clin Cancer Res 2010, 29:51.
55. Toyonaga T., Nakano K., Nagano M., Zhao G., Yamaguchi K., Kuroki S., et al. Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer. Cancer Lett 2003, 201:107-116.
56. Feurino L.W., Fisher W.E., Bharadwaj U., Yao Q., Chen C., Li M. Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values. Cancer Invest 2006, 24:696-703.
57. Block K.M., Hanke N.T., Maine E.A., Baker A.F. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines. Pancreas 2012, 41:773-781.
58. Bharadwaj U., Marin-Muller C., Li M., Chen C., Yao Q. Mesothelin confers pancreatic cancer cell resistance to TNF-alpha-induced apoptosis through Akt/PI3K/NF-kappaB activation and IL-6/Mcl-1 overexpression. Mol Cancer 2011, 10:106.
59. Hoffmann J., Junker H., Schmieder A., Venz S., Brandt R., Multhoff G., et al. EGCG downregulates IL-1RI expression and suppresses IL-1-induced tumorigenic factors in human pancreatic adenocarcinoma cells. Biochem Pharmacol 2011, 82:1153-1162.
60. Denley S.M., Jamieson N.B., McCall P., Oien K.A., Morton J.P., Carter C.R., et al. Activation of the IL-6R/Jak/stat pathway is associated with a poor outcome in resected pancreatic ductal adenocarcinoma. J Gastrointest Surg 2013, 17:887-898.
61. Rouquier S., Lowe J.B., Kelly R.J., Fertitta A.L., Lennon G.G., Giorgi D. Molecular cloning of a human genomic region containing the H blood group alpha(1,2)fucosyltransferase gene and two H locus-related DNA restriction fragments. Isolation of a candidate for the human Secretor blood group locus. J Biol Chem 1995, 270:4632-4639.
62. Taniuchi F., Higai K., Tanaka T., Azuma Y., Matsumoto K. Transcriptional regulation of fucosyltransferase 1 gene expression in colon cancer cells. Sci World J 2013, 2013:105464.
63. Wang X., Vertino A., Eddy R.L., Byers M.G., Jani-Sait S.N., Shows T.B., et al. Chromosome mapping and organization of the human beta-galactoside alpha 2,6-sialyltransferase gene. Differential and cell-type specific usage of upstream exon sequences in B-lymphoblastoid cells. J Biol Chem 1993, 268:4355-4361.
64. Lo N.W., Lau J.T. Novel heterogeneity exists in the 5'-untranslated region of the beta-galactoside alpha 2,6-sialytransferase mRNAs in the human B-lymphoblastoid cell line, louckes. Biochem Biophys Res Commun 1996, 228:380-385.
65. Hanasaki K., Varki A., Stamenkovic I., Bevilacqua M.P. Cytokine-induced beta-galactoside alpha-2,6-sialyltransferase in human endothelial cells mediates alpha 2,6-sialylation of adhesion molecules and CD22 ligands. J Biol Chem 1994, 269:10637-10643.
66. Sarrats A., Saldova R., Pla E., Fort E., Harvey D.J., Struwe W.B., et al. Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics Clin Appl 2010, 4:432-448.
67. Majuri M.L., Niemela R., Tiisala S., Renkonen O., Renkonen R. Expression and function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors. Int J Cancer 1995, 63:551-559.
68. Stefani A.L., Basso D., Panozzo M.P., Greco E., Mazza S., Zancanaro F., et al. Cytokines modulate MIA PaCa 2 and CAPAN-1 adhesion to extracellular matrix proteins. Pancreas 1999, 19:362-369.
69. Bassaganas S., Perez-Garay M., Peracaula R. Cell surface sialic acid modulates extracellular matrix adhesion and migration in pancreatic adenocarcinoma cells. Pancreas 2014, 43:109-117.
70. Bassaganas S., Carvalho S., Dias A.M., Perez-Garay M., Ortiz M.R., Figueras J., et al. Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of alpha2beta1 integrin and E-cadherin function. PLoS One 2014, 9:e98595.